题名

Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug

DOI

10.4103/2225-4110.139103

作者

Shridhar Dwivedi；Deepti Chopra

关键词

Antioxidant ； Cardiovascular disorders ； Coronary prevention ； Flavonoids ； Terminalia arjuna ； Triterpenoids

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

4卷4期（2014 / 10 / 01）

页次

224 - 231

内容语文

英文
中文摘要

Terminalia arjuna, commonly known as arjuna, belongs to the family of Combretaceae. Its bark decoction is being used in the Indian subcontinent for anginal pain, hypertension, congestive heart failure, and dyslipidemia, based on the observations of ancient physicians for centuries. The utility of arjuna in various cardiovascular diseases needs to be studied further. Therefore, the present review is an effort to give a detailed survey of the literature summarizing the experimental and clinical studies pertinent to arjuna in cardiovascular disorders, which were particularly performed during the last decade. Systematic reviews, meta-analyses, and clinical studies of arjuna were retrieved through the use of PubMed, Google Scholar, and Cochrane databases. Most of the studies, both experimental and clinical, have suggested that the crude drug possesses anti-ischemic, antioxidant, hypolipidemic, and antiatherogenic activities. Its useful phytoconstituents are: Triterpenoids, β-sitosterol, flavonoids, and glycosides. Triterpenoids and flavonoids are considered to be responsible for its beneficial antioxidant cardiovascular properties. The drug has shown promising effect on ischemic cardiomyopathy. So far, no serious side effects have been reported with arjuna therapy. However, its long-term safety still remains to be elucidated. Though it has been found quite useful in angina pectoris, mild hypertension, and dyslipidemia, its exact role in primary/secondary coronary prevention is yet to be explored.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Antani, JA,Gandhi, S,Antani, NJ(1991).Terminalia arjuna in congestive heart failure (Abstract).J Assoc Physicians India,39,801.
  2. Arjuna. In hand book on medicinal and aromatic plants. Available from: http://assamagribusiness.nic.in/nedfi/map17.pdf. [Last accessed on 2014 Jan 26].
  3. Bharani, A,Ahirwar, LK,Jain, N(2004).Terminalia arjuna reverses impaired endothelial function in chronic smokers.Indian Heart J,56,123-128.
  4. Bharani, A,Ganguli, A,Mathur, LK,Jamra, Y,Raman, PG(2002).Efficacy of Terminaliaarjuna in chronic stable angina: A double‑blind, placebo‑controlled, crossover study comparing Terminalia arjuna with isosorbidemononitrate.Indian Heart J,54,170-175.
  5. Bharani, A,Ganguly, A,Bhargava, KD(1995).Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.Int J Cardiol,49,191-199.
  6. Bhatia, J,Bhattacharya, SK,Mahajan, P,Dwivedi, S(1998).Effect of Terminalia arjuna on coronary flow–an experimental study (Abstract).Indian J Pharmacol,30,118.
  7. Bhawania, G,Kumar, A,Murthy, KS,Kumari, N,Swami, CG(2013).Aretrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy.J Pharm Res,6,493-498.
  8. Chander, R,Singh, K,Khanna, AK,Kaul, SM,Puri, A,Saxena, R(2004).Antidyslipidemic and antioxldant activities of different fractions of terminaliaarjuna stem bark.Indian J Clin Biochem,19,141-148.
  9. Chopra, RN,Chopra, IC,Handa, KL,Kapur, LD(1958).Terminalia arjuna W and A (Combretaceae).Chopra’s Indigenous Drugs of India,Calcutta, India:
  10. Dhingra, V,Dhingra, S,Singla, A(2013).Forensic and pharmacognostic studies of the Terminalia Arjuna Bark.Egypt J Forensic Sci,3,15-19.
  11. Dwivedi, S(2007).Terminalia arjuna Wight and Arn.—A useful drug for cardiovascular disorders.J Ethnopharmacol,1,114-129.
  12. Dwivedi, S,Agarwal, MP(1994).Antianginal and cardioprotective effects of Terminaliaarjuna, an indigenous drug, in coronary artery disease.JAssoc Physicians India,42,287-289.
  13. Dwivedi, S,Aggarwal, A,Agarwal, MP,Rajpal, S(2005).Role of Terminalia arjuna in ischaemic mitral regurgitation.Int J Cardiol,100,507-508.
  14. Dwivedi, S,Chansouria, JP,Somani, PN,Udupa, KN(1989).Effect of Terminalia arjuna on ischaemic heart disease.Altern Med,3,115-122.
  15. Dwivedi, S,Jauhari, R(1997).Beneficial effects of Terminalia arjuna in coronary artery disease.Indian Heart J,49,507-510.
  16. Dwivedi, S,Kumar, V(2007).Beta‑thalassemia, hyperlipoproteinaemia(a) and metabolic syndrome: Its low cost holistic therapy.J Altern Complement Med,13,287-289.
  17. Gauthaman, K,Maulik, M,Kumari, R,Manchanda, SC,Dinda, AK,Maulik, SK(2001).Effect of chronic treatment with bark of Terminalia arjuna: A study on the isolated ischemic‑reperfused rat heart.JEthnopharmacol,75,197-201.
  18. Gauthaman, K,Mohamed, Saleem, TS,Ravi, V,Patel, SS,Niranjali, S,Devaraj, R(2008).Alcoholic extract of terminalia arjuna protects rabbit heart against ischemic‑reperfusion injury: Role of antioxidant enzymes and heat shock protein.World Acad Sci Eng Technol,18,488-498.
  19. Gupta, R,Singhal, S,Goyle, A,Sharma, VN(2001).Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree‑bark powder: A randomised placebo‑controlled trial.J Assoc Physicians India,49,231-235.
  20. Haq, AM,Huque, MM,Chaudhury, SA,Haque, MN(2012).Cardiotonic effects of Terminalia arjuna extracts on guinea pig heart in vitro.Bangladesh J Pharmacol,7,164-168.
  21. Jain, S,Yadav, PP,Gill, V,Vasudeva, N,Singla, N(2009).Terminalia arjuna a sacred medicinal plant: Phytochemical and pharmacological profile.Phytochem Rev,8,491-502.
  22. Jain, V,Poonia, A,Agarwal, RP,Panwar, RB,Kochar, DK,Mishra, SN(1992).Effect of Terminalia arjuna in patients of angina pectoris(A clinical trial).Indian Med Gaz,36,56-59.
  23. Khalil, S(2005).,New Delhi, India:National Board of Examination.
  24. Khanna, AK,Chander, C,Kapoor, NK(1996).Terminalia arjuna: An Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats.Phytother Res,10,663-665.
  25. Kokkiripati, PK,Kamsala, RV,Bashyam, L,Manthapuram, N,Bitla, P,Peddada, V(2013).Stem‑bark of Terminalia arjuna attenuates human monocytic (THP‑1) and aortic endothelial cell activation.J Ethnopharmacol,146,456-464.
  26. Kumar, G,Srivastava, A,Sharma, SK,Gupta, YK(2012).Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and ArogyavardhiniVati) in dyslipidemia patients: A pilot prospective cohort clinical study.Ayu,33,197-201.
  27. Kumar, PU,Adhikari, P,Pereira, P,Bhat, P(1999).Safety and efficacy of Hartone in stable angina pectoris–an open comparative trial.J Assoc Physicians India,47,685-689.
  28. Kumar, S,Enjamoori, R,Jaiswal, A,Ray, R,Seth, S,Maulik, SK(2009).Catecholamine‑induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.).J Pharm Pharmacol,61,1529-1536.
  29. Malik, N,Dhawan, V,Bahl, A,Kaul, D(2009).Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease.Platelets,20,183-190.
  30. Manna, P,Sinha, M,Sil, PC(2007).Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress.Pathophysiology,14,71-78.
  31. Maulik, SK,Talwar, KK(2012).Therapeutic potential of Terminalia arjuna in cardiovascular disorders.Am J Cardiovasc Drugs,12,157-163.
  32. Muthu, C,Ayyanar, M,Raja, N,Ignacimuthu, S(2006).Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India.J Ethnobilol Ethnomed,2,43.
  33. Mythili, P,Parameswari, CS,Dayana, J(2012).Phytochemical analysis of the bark extract of Terminalia arjuna and its cardioprotective effect.Indian J Innov Dev,1,40-42.
  34. Nammi, S,Gudavalli, R,Babu, BS,Lodagala, DS,Boini, KM(2003).Possible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs.BMC Complement Altern Med,3,5.
  35. Nema, R,Jain, P,Khare, S,Pradhan, A,Gupta, A,Singh, D(2012).Preliminary phytochemical evaluation and flavanoids quantification of Terminalia arjuna leaves extract.Int J Pharm Phytopharmacol Res,1,283-286.
  36. Oberoi, L,Akiyama, T,Lee, KH,Liu, SJ(2011).The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes.Phytomedicine,18,259-265.
  37. Paarakh, PM(2010).Terminalia arjuna (Roxb.) Wt. and Arn.: A review.Int J Pharmacol,6,515-534.
  38. Parmar, HS,Panda, S,Jatwa, R,Kar, A(2006).Cardio‑protective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones.Pharmazie,61,793-795.
  39. Parveen, A,Babbar, R,Agarwal, S,Kotwani, A,Fahim, M(2011).Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol‑induced chronic heart failure in rats.CardiovascToxicol,11,48-57.
  40. Pathak, SR,Upadhya, L,Singh, RN(1990).Effect of Terminalia arjuna on lipid profile of rabbit fed hypercholesterolemic diet.Int J Crude Drug Res,28,48-51.
  41. Patil, RH,Prakash, K,Maheshwari, VL(2011).Hypolipidemic effect of Terminalia arjuna (L.) in experimentally induced hypercholesteremic rats.Acta Biol Szeged,55,289-293.
  42. Pingali, U,Fatima, N,Nizampatnam, M(2013).Evaluation of Terminalia arjuna on cardiovascular parameters and platelet aggregation in patients with Type II diabetes mellitus.Res J Life Sci,1,7-12.
  43. Prusti, AB,Behera, KK(2007).Ethnobotanical exploration of Malkangiri district of Orissa, India.Ethnobot Leafl,11,122-140.
  44. Prusti, AB,Behera, KK(2007).Ethno‑Medico Botanical Study of Sundargarh district, Orissa, India.Ethnobot Leafl,11,148-163.
  45. Ram, A,Lauria, P,Gupta, R,Kumar, P,Sharma, VN(1997).Hypocholesterolaemic effects of Terminaliaarjuna tree bark.J Ethnopharmacol,55,165-169.
  46. Reddy, TK,Seshadri, P,Reddy, KK,Jagetia, GC,Reddy, CD(2008).Effect of Terminalia arjuna extract on adriamycin‑induced DNA damage.Phytother Res,22,1188-1194.
  47. Sandhu, JS,Shah, B,Shenoy, S,Chauhan, S,Lavekar, GS,Padhi, MM(2010).Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults.Int J Ayurveda Res,1,144-149.
  48. Shahriar, M,Akhter, S,Hossain, MI,Haque, MA,Bhuiyan, MA(2012).Evaluation of in vitro antioxidant activity of bark extracts of Terminalia arjuna.J Med Plants Res,6,5286-5298.
  49. Shahriar, M,Sharmin, FA,Islam, SMA,Dewan, I,Kabir, S(2012).Membrane stabilizing and anti‑thrombolytic activities of four medicinal Plants of Bangladesh.Experiment,4,265-270.
  50. Sharma, S,Sharma, D,Agarwal, N(2012).Diminishing effect of arjuna tree (Terminalia arjuna) bark on the lipid and oxidative stress status of high fat high cholesterol fed rats and development of certain dietary recipes containing the tree bark for human consumption.Res Pharm,2,22-30.
  51. Singh, G,Singh, AT,Abraham, A,Bhat, B,Mukherjee, A,Verma, R(2008).Protective effects of Terminaliaarjuna against Doxorubicin‑induced cardiotoxicity.J Ethnopharmacol,117,123-129.
  52. Singh, N,Kapur, KK,Singh, SP,Shankar, K,Sinha, JN,Kohli, RD(1982).Mechanism of cardiovascular action of Terminalia arjuna.Planta Med,45,102-104.
  53. Sinha, M,Manna, P,Sil, PC(2008).Terminalia arjuna protects mouse hearts against sodium fluoride‑induced oxidative stress.J Med Food,4,733-740.
  54. Subramaniam, S,Ramachandran, S,Uthrapathi, S,Gnamanickam, VR,Dubey, GP(2011).Anti‑hyperlipidemic and antioxidant potential of different fractions of TerminaliaarjunaRoxb. bark against PX‑ 407 induced hyperlipidemia.Indian J Exp Biol,49,282-288.
  55. Subramaniam, S,Subramaniam, R,Rajapandian, S,Uthrapathi, S,Gnanamanickam, VR,Dubey, GP(2011).Anti‑atherogenic activity of ethanolic fraction of terminaliaarjuna bark on hypercholesterolemic rabbits.Evid Based Complement Alternat Med,2011,487916.
  56. Sumitra, M,Manikandan, P,Kumar, DA,Arutselvan, N,Balakrishna, K,Manohar, BM(2001).Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status.Mol Cell Biochem,224,135-142.
  57. Takahashi, S,Tanaka, H,Hano, Y,Ito, K,Nomura, T,Shigenobu, K(1997).Hypotensive effect in rats of hydrophilic extract from Terminalia arjuna containing tannin‑related compounds.Phytother Res,11,424-427.
  58. Tiwari, AK,Gode, JD,Dubey, GP(1990).Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet.Int J Crude Drug Res,28,43-47.
  59. Tripathi, VK,Singh, B,Jha, RN,Pandey, VB,Udupa, KN(2000).Studies on Arjuna in coronary heart disease.J Res Ayur Siddha,21,37-40.
  60. Tyler VM, Premila MS. Ayurvedic Herbs: AClinical Guide to the Healing Plants of Traditional Indian Medicine. Available from: http://books.google.co.in/books?id=r7JmIeAw9JAC and printsec=frontcover#v=onepage and q and f=false. [Last accessed on 2014 Jan 25].
  61. Varghese, A,Pandita, N,Gaud, RS(2014).In vitro and in vivo evaluation of CYP1a interaction potential of terminalia arjuna bark.Indian J Pharm Sci,76,138-147.
  62. Verma, P,Muneesh,Rani, S,Bhutani, G(2013).Experimental Evaluation of Terminalia arjuna (Aqueous Extract) on cardiovascular system in comparison to digoxin.J Dent Med Sci,7,48-51.
  63. Verma, SK,Bordia, A(1988).Effect of Terminaliaarjuna bark (arjunchhal) in patients of congestive heart failure and hypertension.J Res Educ Indian Med,7,31-36.
  64. Wang, W,Ali, Z,Li, XC,Shen, Y,Khan, IA(2010).18,19‑secooleanane type triterpene glycosyl esters from the bark of Terminalia arjuna.Planta Med,76,903-908.
  65. Wang, W,Ali, Z,Li, XC,Shen, Y,Khan, IA(2010).Triterpenoids from two Terminalia species.Planta Med,76,1751-1754.
  66. Wang, W,Ali, Z,Shen, Y,Li, XC,Khan, IA(2010).Ursane triterpenoids from the bark of Terminalia arjuna.Fitoterapia,81,480-484.
  67. Warrier PK, Nambiar VP, Ramankutty C. Indian Medicinal Plants: ACompendium of 500 Species, Vol. 5. Available from: http://books.google.co.in/books?id=X2yNfl0PbrgC and q=terminalia+arjuna#v=snippet and q=terminalia%20arjuna and f=false. [Last accessed on 2014 Jan 25].
  68. Yadava, RN,Rathore, K(2000).A new cardenolide from the seeds of Terminalia arjuna (W and A).J Asian Nat Prod Res,2,97-101.
  69. Yesodharan, K,Sujana, KA(2007).Ethnomedicinal knowledge among Malamalasar tribe of Parambikulam Wildlife Sanctuary, Kerala.Indian J Tradit Knowledge,6,481-485.
  70. Ygnanarayan, R,Sangle, SA,Sirsikar, SS,Mitra, DK(1997).Regression of cardiac hypertrophy in hypertensive patients—comparison of abana with propanolol.Phytother Res,11,257-259.
被引用次数
  1. Marcelo Alarcón,Manuel Fuentes,Iván Palomo,Eduardo Fuentes,Cesar Sepúlveda(2018).Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling.Journal of Traditional and Complementary Medicine,8(1),66-71.
  2. Vikas Kumar,Prem Kumar Khosla,Nitin Sharma,Kamal Dev,Anuradha Sourirajan(2018).Comparative evaluation of antimicrobial and antioxidant potential of ethanolic extract and its fractions of bark and leaves of Terminalia arjuna from north-western Himalayas, India.Journal of Traditional and Complementary Medicine,8(1),100-106.
print cancel